Kelly Gissendaner: Explaining the ‘Cloudy’ Drug That Stopped Georgia Execution
Published at
Georgia Department of Corrections(ATLANTA) — The execution of a Georgia woman was halted Monday mere hours before she was scheduled to be put to death, after officials said they found the lethal injection drug was “cloudy.”
The delayed execution comes as prisons have faced increased scrutiny over lethal injection procedures. Some drugs traditionally used in lethal injections have become scarce as suppliers have refused to allow the drugs to be used in executions.
Dr. Howard Nearman, an anesthesiologist at University Hospitals Case Medical Center in Cleveland, told ABC News on Tuesday that if the drug was “cloudy,” it could indicate that it was contaminated or a particulate ingredient did not fully disintegrate.
“Those [compounding pharmacies] are notoriously unreliable,” he said before explaining the only supplier currently available is a Danish company, which has tried to restrict the drug so it cannot be used for lethal injections, leaving some prisons to rely on compounding pharmacies.
Pentobarbital is a sedative that causes brain sedation and can lead to coma and, in cases of overdose, respiratory arrest.
Nearman, who had no involvement in this case, said he was also concerned that the people administering the drugs could lack necessary medical expertise, noting the correct dose of a sedative can be difficult to administer correctly.
“The trouble is there’s tremendous variability depending on what drug level is enough,” he said.
Certified anesthesiologists risk losing their certification if they consult or participate in an execution, according to a 2010 notice from the American Board of Anesthesiologists.
Kelly Gissendaner was scheduled to be the first Georgia woman in decades to be executed by lethal injection, in this case with pentobarbital, before the execution was postponed.
Gissendaner was sentenced to death after being convicted of her husband’s murder in 1997.
Follow @ABCNewsRadio
Copyright © 2015, ABC Radio. All rights reserved.